Financials data is unavailable for this security.
View more
Year on year BioAdaptives Inc grew revenues 66.30% from 17.18k to 28.57k while net income improved from a loss of 895.57k to a smaller loss of 712.47k.
Gross margin | 32.04% |
---|---|
Net profit margin | -2,170.86% |
Operating margin | -872.75% |
Return on assets | -2,705.10% |
---|---|
Return on equity | -- |
Return on investment | -- |
More ▼
Cash flow in USDView more
In 2023, BioAdaptives Inc increased its cash reserves by 139.20%, or 35.37k. Cash Flow from Financing totalled 259.14k or 907.04% of revenues. In addition the company used 223.77k for operations while cash used for investing totalled .
Cash flow per share | -0.0006 |
---|---|
Price/Cash flow per share | -- |
Book value per share | -0.0016 |
---|---|
Tangible book value per share | -0.0016 |
More ▼
Balance sheet in USDView more
Current ratio | 0.0045 |
---|---|
Quick ratio | 0.0014 |
Total debt/total equity | -- |
---|---|
Total debt/total capital | -- |
More ▼